ArticleFrontiers in pharmacology2021

Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer-the Experience of a Tertiary Cancer Center.

Călin Căinap et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.